Xaluritamig
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Xaluritamig, covering 2025-12-01 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer [Phase 3]